The Valley Desk

ArticleChemical biology & drug designPublished

Targeted modification of furan-2-carboxaldehydes into Michael acceptor analogs yielded long-acting hemoglobin modulators with dual antisickling activities

Read the publication ↗ Open access copy ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Children’s Hospital of Philadelphia. Affiliation source

Publication record

Type
Article
Venue
Chemical biology & drug design
Published
Subject terms
Humans; Anemia, Sickle Cell; Oxygen; Aldehydes; Furans; Hemoglobins; Hemoglobin, Sickle; Antisickling Agents; Hemoglobin; Sickle Cell Disease; Antisickling; Michael Acceptor
PubMed ID
37798397
PubMed Central ID
PMC12309464
Added to directory
Source checked

Report a correction or request removal